The Latest Breaking News from Vaccine

The lawsuit seeks unspecified monetary damages for patent infringement.

Health authorities say the vaccine is safe and effective in this age group

Omicron’s mutations impaired vaccine effectiveness, CDC says

Pfizer (NYSE:PFE) announced positive top-line data from the Phase 3 clinical trial RENOIR investigating its bivalent RSV prefusion F vaccine candidate, RSVpreF, when administered to adults 60 years of age or older. Pfizer, Inc. shares traded in a range of $47.27 to $47.95 on day volume of 14.45 million shares, closed…

Anti-lockdown advocates have been claiming online this week that Victoria's Chief Health Officer Brett Sutton admitted that vaccines never worked. But that's not what he said.

NEW YORK — Novak Djokovic’s refusal to get the COVID-19 vaccine has seemingly cost him another shot at a tournament.

From next week people in Ireland who are at high risk of getting monkeypox will be offered a dose.

COVID-19 vaccines tweaked to better match today’s omicron threat are expected to roll out in a few weeks but how much will they help

Intensive ABC drive to be launched across State